Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Arstasis
AddedFeb 15, 2024
UpdatedJun 18, 2026
Arstasis

Arstasis

Series B

Arstasis: Innovating cardiac device manufacturing for enhanced clinical procedures since 2006.

HQ
Redwood City, CA, US
Founded
2004
Overview
Compare
Fundraising
Employees
Website

Founded in 2006 and headquartered in Redwood City, California, Arstasis is a medical device manufacturer focused on providing innovative access devices for cardiologists and interventional radiologists. The company's core mission is to enhance clinical procedures and improve patient outcomes through its flagship product used in the Arstaotomy™ procedure. This novel technique aims to offer a more efficient and pleasant experience in the cath lab and post-procedure for both clinicians and patients.

Arstasis has garnered attention for its pioneering approach in the medical device industry, attracting notable investors and affiliations within the healthcare sector. The company's key achievements include the successful implementation of the Arstaotomy™ procedure, which has been well-received by medical professionals for its potential to streamline arterial access. Through its innovative solutions, Arstasis has made a significant impact on the field of interventional cardiology, contributing to advancements in patient care and procedural efficiency.

Arstasis - Quick Facts

When was Arstasis founded?

Arstasis was founded in 2004.

Where is Arstasis' headquarters located?

Arstasis' headquarters is located in Redwood City, CA, US.

When was Arstasis' last funding round?

Arstasis' most recent funding round was for $16.5M (USD) in November 2013.

How much has Arstasis raised to-date?

As of Nov 18, 2013, Arstasis has raised a total of $95.4M (USD).

How many employees does Arstasis have?

Arstasis has 75 employees as of Feb 5, 2024.

Arstasis - Classification

Industry
  • Hardware
Ownership
  • Private
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Medical Devices
Tags
  • Healthtech
  • Medical
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies
ISIC
  • 8522Technical and vocational secondary education
Show 14 more industry codes
NAICS
  • 610000Educational Services
  • 611400Business Schools and Computer and Management Training
  • 611410Business and Secretarial Schools
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 611000Educational Services
  • 623000Nursing and Residential Care Facilities
SIC
  • 8240Vocational Schools
  • 8244Business and Secretarial Schools
  • 3900Miscellaneous Manufacturing Industries
  • 8000Health Services
  • 8200Educational Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified